Stroke is a leading cause of disability and death worldwide. Early recognition and prompt management of stroke can significantly improve patient outcomes. This article provides a comprehensive guide for healthcare professionals in recognizing and managing stroke in its early stages.
A stroke occurs when blood flow to a part of the brain is interrupted, leading to rapid loss of brain function. The acronym F.A.S.T. (Face, Arms, Speech, Time) is a simple tool that can help in early recognition. Facial drooping, arm weakness, speech difficulties are warning signs of a stroke. Time is critical in stroke management; the sooner the patient receives medical care, the better the prognosis.
Upon suspicion of a stroke, a rapid neurological assessment should be performed. The National Institutes of Health Stroke Scale (NIHSS) is a valuable tool for quantifying stroke severity. A higher score on the NIHSS correlates with more severe strokes and worse outcomes.
Imaging plays a crucial role in the early management of stroke. A non-contrast CT scan of the head is typically the first imaging modality used to differentiate between ischemic and hemorrhagic stroke. Advanced imaging techniques like CT angiography and perfusion imaging can provide additional information about the extent of the stroke and the presence of salvageable brain tissue.
Once a stroke is confirmed, immediate treatment is necessary. For ischemic strokes, intravenous thrombolysis with alteplase is the first-line treatment if administered within 4.5 hours of symptom onset. In selected cases, endovascular therapy may be beneficial. For hemorrhagic strokes, controlling blood pressure and reversing anticoagulation are crucial initial steps.
Early recognition and management of stroke can significantly improve patient outcomes. Healthcare professionals play a critical role in this process. By staying updated on the latest evidence-based practices, we can ensure that our patients receive the best possible care in the crucial early stages of stroke.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation